
Opinion|Videos|October 12, 2023
Leveraging MRI and Fusion-Guided Biopsy for Active Surveillance in Prostate Cancer
Author(s)Amir H. Lebastchi, MD
Amir H. Lebastchi, MD, outlines his general strategy for active surveillance in prostate cancer patients, emphasizing the role of MRI and fusion-guided prostate biopsy.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
2
Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC
3
Real-World Evidence in mCSPC Management
4
Jim Hu, MD, discusses new posterior approach to nerve-sparing prostatectomy
5




















